ENTITY
Sun Pharma

Sun Pharma (SUNP IN)

353
Analysis
Health Care • India
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs). It offers a wide range of products across chronic and acute therapies, including generics, branded generics, and specialty products. The company was founded in 1983 and is headquartered in Mumbai, India.
more
bearish•Aequs Ltd
•04 Jun 2026 10:37

Aequitas: Aequs Ltd IPO Lockup Expiry - US$933m Lockup Release

Aequs Ltd raised about US$104m in its India IPO in Dec 2025. The lockup on its promoters and pre-IPO investors is set to expire soon.

Logo
167 Views
Share
•13 Dec 2018 12:54

India On Ground: Local Fund Managers Still Debate Valuations,OK with News Flow but Expect Volatility

Last few months have been stressful for domestic fund managers and more than the sudden market movement, much increased volatility even in large...

Logo
640 Views
Share
•10 Dec 2018 10:01

India: Results Tomorrow, But Will Exit Polls for Assembly Elections Make the Markets More Nervous?

While the Exit Polls have a mixed record and their findings especially in very close contests could be completely different vs. final results, the...

Logo
423 Views
Share
•06 Nov 2018 20:03

Para IV Winners and Losers - October 2018

This month’s Para IV developments suggest that there can be benefit for Amneal Pharmaceuticals Inc (AMRX US) in Xyren and Faslodex, Wockhardt Ltd...

Logo
549 Views
Share
•20 Sep 2018 21:49

Global Equity Strategy: Opportunities in Japan and India

Our outlook for ex-U.S. markets (MSCI ACWI ex-U.S. index, local currency) remains neutral - bordering on cautious. Our concern stems from the...

Logo
635 Views
Share
x